Histone modification: the 'next wave' in cancer therapeutics

被引：20

作者：

Chung, D

机构：

来源：

TRENDS IN MOLECULAR MEDICINE | 2002年 / 8卷 / 04期

关键词：

D O I：

10.1016/S1471-4914(02)02303-1

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：S10 / S11

页数：2

共 8 条

[1] Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes [J].

Boggs, BA ;

Cheung, P ;

Heard, E ;

Spector, DL ;

Chinault, AC ;

Allis, CD .

NATURE GENETICS, 2002, 30 (01) :73-76

[2] Mutations truncating the EP300 acetylase in human cancers [J].

Gayther, SA ;

Batley, SJ ;

Linger, L ;

Bannister, A ;

Thorpe, K ;

Chin, SF ;

Daigo, Y ;

Russell, P ;

Wilson, A ;

Sowter, HM ;

Delhanty, JDA ;

Ponder, BAJ ;

Kouzarides, T ;

Caldas, C .

NATURE GENETICS, 2000, 24 (03) :300-303

[3] Translating the histone code [J].

Jenuwein, T ;

Allis, CD .

SCIENCE, 2001, 293 (5532) :1074-1080

[4] Histone acetylases and deacetylases in cell proliferation [J].

Kouzarides, T .

CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (01) :40-48

[5] Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin [J].

Peters, AHFM ;

Mermoud, JE ;

O'Carroll, D ;

Pagani, M ;

Schweizer, D ;

Brockdorff, N ;

Jenuwein, T .

NATURE GENETICS, 2002, 30 (01) :77-80

[6] Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability [J].

Peters, AHFM ;

O'Carroll, D ;

Scherthan, H ;

Mechtler, K ;

Sauer, S ;

Schöfer, C ;

Weipoltshammer, K ;

Pagani, M ;

Lachner, M ;

Kohlmaier, A ;

Opravil, S ;

Doyle, M ;

Sibilia, M ;

Jenuwein, T .

CELL, 2001, 107 (03) :323-337

[7] The language of covalent histone modifications [J].

Strahl, BD ;

Allis, CD .

NATURE, 2000, 403 (6765) :41-45

[8]

Workman Paul, 2001, Current Opinion in Pharmacology, V1, P342, DOI 10.1016/S1471-4892(01)00060-1

← 1 →